Acceder

Análisis técnico y gráfico histórico de Organon&Company

Análisis fundamental y estadísticas clave de Organon&Company

Ficha de Organon&Company (OGN)

Ticker OGN
ISIN US68622V1061
Sector Atención sanitaria
Mercado NYSE

Análisis financiero de Organon&Company

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Organon&Company

Invertir en Organon&Company en 2026: Preguntas frecuentes

¿Qué es Organon&Company?

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It al...

¿En qué sector opera Organon&Company?

Organon&Company opera en el sector Healthcare, industria Drug Manufacturers - General.